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The prevalence of asthma has increased
dramatically over the last 25 years in the
United States and in other industrialized
nations as a result of ill-defined changes in liv-
ing conditions in modern Western society
(Pew Environmental Health Commission
2000; Mannino et al. 2002). Exposure to air
pollutants, including tobacco smoke, ozone,
and diesel exhaust, increases the risk of devel-
oping asthma (Gilmour et al. 2006) and may
be contributing to this trend. In addition,
indoor exposures to allergens and to other bio-
logics have been implicated in the increased
incidence of asthma because more time is
spent indoors and indoor environments have
been made more airtight to improve energy
efficiency (Bush 2001; Zeldin et al. 2006).
However, other factors, including increased
incidence of obesity, decreased exercise,
change in diet, decreased exposure to micro-
bial products during early life (the hygiene
hypothesis), and increased viral respiratory
infections (e.g., from daycare facilities), are all
possible contributors to the rise in asthma
incidence (Yeatts et al. 2006). Although chil-
dren appear to be the population most at risk,
there is growing concern that new cases are
also arising in adults (Enright et al. 1999).
Induction of atopic phenotype (Nguyen et al.
2003) and asthma (Gautrin et al. 2001) have
both been well documented in adults in occu-
pational settings.
On 18 and 19 October 2004 the
U.S. Environmental Protection Agency (EPA)
and National Institute of Environmental
Health Sciences sponsored the workshop
“Environmental Influences on the Induction
and Incidence of Asthma.” The workshop
focused on the origin of disease rather than on
exacerbation of existing disease because the for-
mer is a more challenging problem and the
ultimate goal is prevention. The purpose of
this workshop was to review the current scien-
tific evidence with respect to factors that may
contribute to the induction (Gilmour et al.
2006; Yeatts et al. 2006; Zeldin et al. 2006)
and, therefore, increased incidence of asthma.
Participants addressed two broad questions:
a) What does the science suggest that regula-
tory and public health agencies could do now
to reduce the incidence of asthma? and
b) What research is needed to improve our
understanding of the factors that contribute to
the induction of asthma and to improve our
ability to manage this problem in the future?
Participants broke into working groups at the
end of the workshop to consider these two
questions and to develop recommendations.
In this article, we provide a brief charac-
terization of asthma and the public health and
economic impacts of this disease as well as a
brief description of intervention strategies
used to prevent induction of asthma in occu-
pational settings. We conclude with a sum-
mary of the findings of the workshop based
on the deliberation of seven working groups.
These findings are focused on ambient
(outdoor) air, indoor pollutants (biologics),
occupational exposures, early life stages
(development), older adults and the aged,
intrinsic (genetic) susceptibility, and lifestyle.
The subsequent three articles in this series
provide a more in-depth picture of the
important contributions of allergens and
other biologics (Zeldin et al. 2006), ambient
air pollutants and cigarette smoke (Gilmour
et al. 2006), and susceptibility factors such as
age, genetics, and obesity (Yeatts et al. 2006)
to the induction of asthma as well as a more
detailed view of research needs and potential
intervention strategies.
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The prevalence of asthma has increased dramatically over the last 25 years in the United States
and in other nations as a result of ill-defined changes in living conditions in modern society. On
18 and 19 October 2004 the U.S. Environmental Protection Agency and the National Institute of
Environmental Health Sciences sponsored the workshop “Environmental Influences on the Induction
and Incidence of Asthma” to review current scientific evidence with respect to factors that may con-
tribute to the induction of asthma. Participants addressed two broad questions: a) What does the sci-
ence suggest that regulatory and public health agencies could do now to reduce the incidence of
asthma? and b) What research is needed to improve our understanding of the factors that contribute
to the induction of asthma and our ability to manage this problem? In this article (one of four articles
resulting from the workshop), we briefly characterize asthma and its public health and economic
impacts, and intervention strategies that have been successfully used to prevent induction of asthma in
the workplace. We conclude with the findings of seven working groups that focus on ambient air,
indoor pollutants (biologics), occupational exposures, early life stages, older adults, intrinsic suscepti-
bility, and lifestyle. These groups found strong scientific support for public health efforts to limit
in utero and postnatal exposure to cigarette smoke. However, with respect to other potential types of
interventions, participants noted many scientific questions, which are summarized in this article.
Research to address these questions could have a significant public health and economic impact that
would be well worth the investment. Key words: air pollution, allergy, asthma economic impact,
asthma induction, asthma prevalence, biologics, indoor environment, occupational exposure, public
health, susceptibility. Environ Health Perspect 114:615–619 (2006). doi:10.1289/ehp.8376 available
via http://dx.doi.org/ [Online 26 January 2006]
What Is Asthma?
Dealing with asthma means many different
things to different people. To the patient, it
means episodic wheezing, coughing, and/or
shortness of breath. To the parent, it may mean
sleepless nights or missed workdays because of
the presence of symptoms in their child. To the
clinician, asthma is a complex condition that
presents as multiple different phenotypes that
can vary with age, gender, and race. Moreover,
the frequency and severity of asthma “attacks”
may have both inter- and intrapatient variabil-
ity and can be triggered by diverse stimuli
including aeroallergen exposure, viral infec-
tions, exercise, irritant exposure, certain medi-
cations (e.g., aspirin), and gastroesophageal
reflux. To the pathologist, asthma is character-
ized by airway inflammation and mucus
hypersecretion. To the physiologist, airflow
obstruction and airway hyperresponsiveness
are most relevant (Lemanske and Busse 2003).
The increases in the incidence, prevalence
(incidence × duration), morbidity, and mor-
tality from asthma during the past few decades
in many parts of the world have led to
renewed consideration of this disease by
researchers both in basic and clinical science.
A number of expert panels across several coun-
tries throughout the world, including the
National Asthma Education and Prevention
Program funded by the National Heart, Lung,
and Blood Institute in the United States
(NHLBI 1991, 1997), have been assembled to
generate pathophysiological definitions of
asthma and to make treatment recommenda-
tions based on disease severity [American
Academy of Allergy and Immunology (AAAI)
et al. 1995; Boulet et al. 1999; British Thoracic
Society 1997; Eid 2004; Thole et al. 2003).
The major emphasis of the 1991 NHLBI
asthma guidelines (NHLBI 1991) was that
asthma was an inflammatory disease; thus,
while bronchospasm was clearly contributing to
the clinical symptoms both acutely and chroni-
cally, research in the 1980s that included both
bronchoalveolar lavage and bronchial biopsies
demonstrated clearly the presence of ongoing
airway inflammation. In 1997 the primary
focus of the expert panels was on the early
recognition and treatment of asthma to prevent
or attenuate a loss of lung function over time.
Prospective birth cohort studies have
revealed that for many asthmatic patients the
disease has its roots in infancy (Gerritsen 2002;
Taussig et al. 2003). Indeed, wheezing in chil-
dren younger than 3 years has been found to be
associated with the presence of inflammatory
cells and mediators (Krawiec et al. 2001).
Wheezing is common during infancy and early
childhood because of the increased frequency of
viral respiratory tract infections and small air-
way diameters (Cypcar et al. 1992). Exposure
to cigarette smoke has also been associated with
wheezing in the first year of life (Hagendorens
et al. 2005). Allergen exposure in early life has
been linked to allergic sensitization and later
asthma, but there is little evidence for an associ-
ation between early allergen exposure and
wheezing in infants or children under 5 years of
age (Sporik et al. 1990; Brussee et al. 2005).
Distinguishing children who will be transient
wheezers from those who will be persistent
wheezers during later childhood has been a
challenge to the clinician in terms of whom to
treat, when to treat, and with what to treat
during this time period (Taussig et al. 2003).
In the first decade of life, males outnumber
females with asthma about 2.5:1. The sex bal-
ance becomes relatively equal during adoles-
cence (related to remission in males and new
onset in females), and in adults, female asth-
matic patients tend to outnumber males
(King et al. 2004). More important, however,
the disease is usually more severe in adult
female patients.
The majority of medications currently
available to treat asthma is very useful in con-
trolling clinical symptoms. Unfortunately, these
medications merely control symptoms, they do
not cure the disease. Thus, the concept of both
secondary and primary prevention is now being
addressed by a number of research groups.
The Public Health and
Economic Impacts
Asthma is a substantial public health burden,
particularly for children, both in the number of
people affected by the disease, and the related
morbidity and cost. Globally, as many as
300 million people of all ages and all ethnic
backgrounds suffer from asthma and the burden
of this disease to governments, health care sys-
tems, families, and patients is increasing world-
wide [Global Initiative for Asthma (GINA)
2004]. It is estimated that 21 million people in
the United States currently have asthma, based
on U.S. Centers for Disease Control and
Prevention (U.S. CDC) Behavioral Risk Factor
Surveillance System data (U.S. CDC 2004).
Within this population 11.8 million Americans
(4.2 million children under 18 years of age) had
an asthma episode or attack during the same
year. Fourteen million missed school days and
14.5 million missed workdays annually have
been attributed to asthma (U.S. CDC 2002).
Annually, nearly 1.9 million emergency depart-
ment visits (U.S. CDC 2002) and 11.3 million
physician office visits have been attributed to
asthma (NHLBI 2004). Primary hospitaliza-
tions caused by asthma were estimated at
484,000 in 2002 (NHLBI 2004). In the same
year there were 4,269 asthma-related deaths. 
The economics of asthma can be divided
into both direct and indirect costs. The direct
costs of asthma include asthma management
programs, inpatient and outpatient medical
care, physician services, emergency visits, and
medication. The projected cost of treating
asthma in those younger than 18 years is
$3.2 billion per year. Overall, the annual direct
health care cost attributable to asthma is esti-
mated to be approximately $11.5 billion. Some
of the indirect costs of asthma include absence
from work and school, activity limitations, sleep
disturbances, and at its most extreme, death.
Costs most difficult to measure are anxiety,
pain, suffering, and decreased potential result-
ing from school absenteeism (Weiss and
Sullivan 2001). Indirect costs (e.g., lost produc-
tivity) account for approximately $4.6 billion,
for a total of $16.1 billion dollars (American
Lung Association 2005; NHLBI 2004).
Intervention: Lessons Learned
from Occupational Asthma
An implicit assumption of this workshop was
that by modifying environmental factors we
could reduce the incidence of asthma.
Experience with occupational asthma (OA),
occurring as a consequence of sensitization to
causative agents in the workplace, provides evi-
dence that it is possible to prevent induction of
asthma in some circumstances by modifying
the work environment. OA accounts for about
15% of asthma in adults (Balmes et al. 2003).
Because exposures in the industrial workplace
are often identifiable, the offending agent can
usually be isolated. Exposures can be monitored
and limited, and medical monitoring can be
conducted to determine the extent of the prob-
lem as well as to identify and treat new cases
(i.e., secondary prevention) and document the
success of preventive interventions. OA devel-
opment, morbidity, and mortality have been
prevented by interventions targeted to different
phases of the disease process, the first two of
which are germane to this workshop. Primary
prevention limits exposure to causative agents
and thus prevents sensitization. Secondary
prevention occurs early in the disease process,
preferably at a preclinical stage, to prevent
progression to full-blown clinical disease.
Interventions to reduce exposure of individuals
to causative agents after they become sensitized
or after development of mild, preclinical air-
ways involvement constitute secondary preven-
tion. Tertiary prevention involves treatment of
established clinical disease to limit morbidity
and mortality as well as limitation of exposure.
An industrial hygiene prevention hierarchy
is employed in the prevention of OA. These
interventions include both early disease
detection and identification and reduction of
workplace exposures. Where possible, substitu-
tion of agents that do not cause OA is the best
alternative. Where substitution is not possible,
engineering and administrative controls can be
used to limit exposures. Use of personal protec-
tive equipment such as respirators is an impor-
tant backup to engineering and administrative
controls, but it should not be the only mode of
prevention because it depends on appropriate
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respirator selection, fit, and function, and
worker adherence to wearing respirators when-
ever needed. Medical screening and surveil-
lance is used to identify affected workers after
sensitization or early after development of air-
ways manifestations but before developing full-
blown OA. Both the affected worker and other
exposed individuals benefit if early detection of
disease leads to identification of sensitizing
agents and reduction of workplace exposures.
Finally, worker education is an important
intervention, allowing workers to recognize
and report hazardous situations. Similar expo-
sure-reducing and education approaches have
been adopted to limit exposure to sensitizing
agents in other indoor environments, and
some success in reducing asthma symptoms in
young children has been demonstrated using
these approaches (Zeldin et al. 2006).
OA has been prevented successfully in
several settings. An impressive example was
elimination of asthma outbreaks in the enzyme
detergent industry in the late 1960s and early
1970s (Cathcart et al. 1997; Schweigert et al.
2000). In this instance a threshold level was
established below which allergic sensitization is
rare and OA does not occur. A more recent
example has been marked reduction in OA
caused by the use of powdered natural rubber
latex gloves in the health care industry (Allmers
et al. 2002). Although the scope of prevention
strategies used in the occupational setting may
be very narrow relative to that which may be
needed in the population as a whole, successes
in this arena do suggest that, given enough
information about the underlying causes and
logistically feasible intervention strategies,
induction of asthma can be prevented, at least
in adults.
Workshop Findings: 
Public Health Measures 
and Research Needs
Following presentations that have been
captured in this and the three articles that fol-
low, workshop participants divided into seven
topic-based discussion groups. Each group
included researchers, regulators, and individu-
als involved in a variety of public health activ-
ities. The charge to the breakout groups was
to consider in the context of their particular
topic area the two broad workshop questions:
a) What does the science suggest that regula-
tory and public health agencies could do now
to reduce the incidence of asthma? and
b) What research is needed to improve our
understanding of the factors that contribute
to the induction of asthma and to improve
our ability to manage this problem in the
future? Having considered these questions,
the groups developed the following set of
workshop conclusions:
Ambient air pollutants. There is sufficient
epidemiologic and animal data to suggest that
some synergism exists between exposure to air
pollutants (primarily outdoor) and biologics
(primarily indoor) in the induction of asthma
in children and possibly adults (Gilmour et al.
2006). However, a number of questions need
to be answered in order to make appropriate
regulatory decisions for ambient air. A coordi-
nated research effort that includes epidemiol-
ogy, clinical, and animal studies is needed to
address the following research questions: 
• Which air pollutants are of greatest concern
and at what concentrations? Is the magnitude
of the inflammatory response (or some other
biomarker) predictive of this effect? What
does the dose–response curve look like? Is
there a threshold? What are the consequences
of acute vs chronic exposure? Are there indi-
rect effects of air pollutants (e.g., climate
change) that could contribute to the problem?
• What is the relative contribution of different
air pollutants to the induction of disease? Is
there synergy (or antagonism) among differ-
ent air pollutants or with other characteris-
tics of western lifestyle (e.g., hygiene, viral
infections, diet)?
• What is the basis of genetic susceptibility,
and has that changed as a result of gene–
environment interaction over the past
20 years in a way that is associated with sus-
ceptibility to air pollutant exposures? Are
there particular periods of life when exposures
to air pollutants are more critical (windows of
vulnerability)?
Indoor air. The discussion of indoor air
pollutants focused on biologics (mold, dust
mite, cockroach and rodent infestations),
dampness, and environmental tobacco smoke
(ETS). As noted earlier, exposure to ETS plays
a role in the development of asthma. Public
health measures to limit exposure to ETS
should reduce the incidence of the disease
(Gilmour et al. 2006; Yeatts et al. 2006). The
potential benefits of reducing exposure to aller-
gens in order to prevent induction of asthma
are less clear. The National Academy of
Sciences (2000) reached a similar conclusion.
Current data indicate that reducing exposure
will reduce morbidity among sensitized chil-
dren who already have asthma but fall short of
linking reduced exposure with a reduction in
incident asthma. Cleaning up and preventing
mold, dust mite, and cockroach and rodent
infestations as well as controlling dampness
will reduce allergens in indoor environments.
However, as noted below, additional research
is needed to develop more effective cleanup
procedures. Education of the public and build-
ing inspectors will promote identification and
clean up of sources of allergens. These impor-
tant first steps should be taken now. At this
time, the development of regulations to assure
home and school environments that are less
likely to contribute to the development of
asthma is precluded by the lack of research
supporting specific interventions. Research is
needed to address the following questions:
• What are the important sources of allergens?
What levels of allergen exposure constitute a
risk for the development of asthma? What is
the relative contribution of different agents
to the development of asthma, and what
medical/health benefits are achieved when
remediation occurs?
• What precautions during the construction
and maintenance of buildings can reduce
indoor exposures to agents likely to be
involved in the development of asthma?
What are the most effective cleanup measures
for contaminated buildings?
• Do previously unrecognized agents (e.g.,
microbial volatile organic compounds, adju-
vant activity, toxins, and/or proteases) pose
a risk with respect to asthma?
• How can (standardized) approaches be
developed for measuring exposures and out-
comes in epidemiologic studies? What are
the best approaches for collecting pollutants
and allergens from different surfaces?
• Is IgE the most appropriate biomarker of
effect? What is the role of non-IgE–mediated
pathways in the development of asthma, and
does this role suggest other biomarkers of
effect that should be considered?
Occupational. As noted earlier the occupa-
tional setting is more controlled than most
other settings (e.g., homes, general outdoor
environment). Where data are sufficient, safe
exposure standards should be set (e.g., wheat
allergen) and maintained. However, there are
approximately 300 occupational asthmagens.
For most of these there are not sufficient data
to set standards nor is it practical to set stan-
dards for each one. A more general approach
includes reducing exposures to known sensitiz-
ers to the lowest levels possible, implementing
medical monitoring for workers exposed to
asthma-inducing agents, and improving the
education (regarding work-related asthma) of
exposed workers, their employers, and the
physicians who treat them. Companies that
produce and/or sell products that contain
known asthma agents should implement prod-
uct stewardship programs to educate workers
in both the parent plants and downstream
user plants. One goal of future research should
be to develop methods to identify potential
asthmagens before they are introduced into
the workplace. Once an asthmagen is recog-
nized, issues with respect to exposure, dose
response, and route of exposure need to be
resolved in order to implement appropriate
controls. The occupational setting provides an
excellent opportunity to maximize the benefit
of coordinated human and animal studies to
address important research questions such as:
• What are the mechanisms associated with
occupationally induced asthma, particularly
in association with low-molecular-weight
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agents (haptens)? (See Yeatts et al. 2006 for
distinction between proteins and haptens in
OA.) Can we develop mechanistically based
tests and/or structure/activity relationships
that would identify the potential to induce
asthma before a chemical is introduced into
the workplace? What is the role of IgE ver-
sus other mechanisms that might contribute
to induction of asthma by low molecular
weight chemicals?
• What are the most appropriate animal models
for asthma, especially when studying low-
molecular-weight agents?
• What are the effects of exposures to combina-
tions of chemicals? How do irritants and sen-
sitizers interact? How do non-work-related
exposure and lifestyle affect the development
of work-related asthma?
• What are the most relevant exposure scenar-
ios? What are the best strategies for assessing
peak exposures? What are the most relevant
routes of exposure? When there are multiple
routes of exposure, how does that impact the
induction of disease?
• What can we learn about genetic susceptibil-
ity and asthma in older adults by studying
occupational settings? Are certain groups
more at risk of developing occupational
asthma, for example, women and certain
ethnic/racial groups, or at higher risk for
asthma in general?
• What are the biomarkers that would be
most appropriate both for animal studies
and medical monitoring? What is the best
approach to implementing medical moni-
toring in the workplace and using the results
to guide preventive interventions? How can
we maximize participation in medical moni-
toring programs?
• What is the best way to demonstrate success-
ful interventions? Which interventions are
the most effective in preventing occupational
asthma?
Early life. Young children are more suscep-
tible than adults to induction of asthma by
environmental factors. The sources of this dis-
parity include different exposure and dose to
tissue characteristics and both qualitative and
quantitative differences in the respiratory,
immune, endocrine, and nervous systems dur-
ing stages of rapid growth and development.
There is much we do not understand about the
risks during the period from gestation through
the first year of life. One thing we do under-
stand is that maternal smoking and exposure to
ETS during this period increases the risk of
developing asthma and that smoking even
before the onset of pregnancy should be consid-
ered a risk (Gilmour et al. 2006; Yeatts et al.
2006). Therefore, public health measures
should include regulations and education
designed to prevent these exposures. The
impact of other types of exposures is less clear.
In particular, conflicting data on the effects of
early life exposures to allergens and bacteria
make it difficult to articulate effective public
health strategies with respect to such exposures.
Viral lower respiratory infections during early
infancy, especially those associated with wheez-
ing, are a risk factor, but reliable methods of
preventing these are not available, and again the
data are inconsistent with some studies suggest-
ing that viral infections have beneficial effects.
Also, little is known about the impact of most
medications or current vaccination strategies on
the development of asthma. 
More research is needed to provide public
health officials with the information they need
to ensure that in utero, home, school, and day
care environments do not contribute to the
induction of asthma during the early stages of
development. Investigators should target chil-
dren specifically for research at these early
stages rather than trying to extrapolate from
them at later stages in life. Efforts should be
made to increase expertise in the area of devel-
opmental biology. Epidemiology and clinical
and animal studies are needed to address the
following questions:
• How do the growth and development of res-
piratory, immune, endocrine, and nervous
systems during gestation and the first year of
life relate to the risks of developing asthma?
What are the critical milestones in develop-
ment of these systems? Can we identify major
windows of vulnerability to environmental
exposures?
• What biomarkers can be identified for evalu-
ating interventions?
• What are the at-risk phenotypes and geno-
types?
• Are there gender differences?
• Do current data support the hygiene hypoth-
esis? Is exposure to some bacteria (e.g., gram-
negative bacteria containing endotoxin) or
other infectious agents during early life bene-
ficial? If so, what kind, how much, and when?
• What is the effect of exposure to allergens dur-
ing gestation and during the first year of life?
Older adults. Asthma incidence and preva-
lence is just as common in older adults as in
younger adults. Although the type of airway
inflammation of asthma differs from that of
chronic obstructive pulmonary disease
(COPD), measures to limit the respiratory
effects of environmental exposures apply
equally to patients with asthma and COPD.
Regulations and education that minimize
exposure of older adults to ETS, criteria air pol-
lutants (ozone, sulfur oxides, nitrogen oxides,
particulate matter), allergens, and volatile
organics are warranted because their respiratory
reserve is less than at younger ages. Because viral
infections in this age group pose significant
health problems that are compounded by
asthma and other types of chronic respiratory
disease, vaccinations for influenza are important
as well as simple hygiene measures such as hand
washing. Older adults deserve more attention
from the asthma research community.
Research needs identified by the ambient
and indoor air breakout groups are also impor-
tant for older adults, so this group should be
included in the design of those studies. In
addition, the following research questions are
unique to this group:
• What specific environmental factors and
individual characteristics increase the risk of
developing new disease in older adults (as
opposed to exacerbation of existing asthma)?
Do these risk factors differ from those for
children?
• What is the natural history of asthma in
older adults?
• What methods will effectively improve the
ability of primary care physicians to diagnose
asthma in older adults?
• Because mortality is a serious problem in this
population, and co-morbidity is common,
what are the risk factors that influence
asthma progressing to death in this group?
Intrinsic (genetic) susceptibility. Consider-
able evidence from family-based studies and
animal models supports a role for genetic
background in the pathogenesis of asthma. A
better understanding of genetic susceptibility
and interaction with environmental factors is
necessary for development of intervention
strategies and a means to identify at-risk
individuals. 
A number of new technologies (e.g.,
genome sequencing and genetic engineering)
are now available to investigate the genetic basis
of complex diseases such as asthma. These tools
provide new opportunities for research that
should ultimately improve the effectiveness of
our public health policies and research design.
Because asthma is a polygenic disease with
important interactions with environmental
exposures, it is necessary to think in a less
reductionistic manner and to emphasize
interaction and communication between epi-
demiologists, clinicians, and basic scientists.
Epidemiology and genomewide scans should be
used in a complementary way. Furthermore,
animal and human studies should be comple-
mentary, with each providing hypotheses for
teting the other. These approaches could help
us to answer the following research questions:
• What is the genetic basis of asthma sub-
phenotypes?
• Are different genes important at different
stages of life, for different types and levels of
exposure?
• What is the impact of environment on
genetic predisposition to asthma (exacerba-
tion and increased incidence)?
Use of genetic information by regulatory
and public health agencies should be considered
in strategies designed to reduce the incidence of
asthma in at-risk populations. Currently, the
higher risk of asthma in certain ethnic and
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socioeconomic groups has raised the issue of
environmental justice in the regulatory arena.
Ethical, economic, and legal considerations
include the following:
• How should genetic counseling be applied
to complex diseases such as asthma?
• What is the most effective way to communi-
cate between scientists and the public about
genetic information without raising concern?
Can genetic information be used to develop
broader public health awareness?
Lifestyle. Because the increased incidence
of asthma seems to be due to some aspect of
“Western” lifestyle, the workshop included a
discussion of how changes in lifestyle apart
from, or in concert with, changes in environ-
mental exposures might influence the induc-
tion and incidence of asthma. Again, ample
evidence that smoking contributes to the
induction of asthma was noted, and public
health actions to discourage smoking, particu-
larly in women of childbearing age and in the
presence of young children, were recom-
mended. Smoking may also contribute to
irreversible airway obstruction in persons with
asthma, thereby further reinforcing the need
to discourage smoking. Rapid urbanization
and its associated “Westernized” lifestyle have
led to decreased activity levels, increased con-
sumption of processed foods, and increased
obesity in the population. All these factors
may contribute singly or in concert to asthma
onset although the relationships need to be
better elucidated. Clearly, interdisciplinary
research with respect to other lifestyle issues is
needed to provide the science necessary for
appropriate public education. 
Apparent links between the increased inci-
dence of asthma and obesity described at this
meeting as well as the potential for other lifestyle
influences suggested several research directions
at both the individual and population levels:
• Are there common mechanisms and/or
causes for the increase in obesity and asthma
(especially in women)?
• How do diet and exercise affect the develop-
ment of asthma? Is there a role for anti-
oxidants, omega-3 fatty acids, nonrefined
carbohydrates, or other additives and nutri-
ents in the prevention of asthma?
• What is the influence of breast milk and
infant diet on the development of asthma in
children? Is there a critical period for breast
feeding? Is maternal diet important during
gestation and breast feeding? Is the mother’s
allergy/asthma status important?
• What is the best way to promote healthy
lifestyles (behavior modification)?
• How does rapid urbanization contribute to
asthma incidence?
• Does stress (not discussed at this meeting
but an issue nonetheless) contribute to the
induction of asthma?
Summary
In the past few decades, increases in the
incidence and prevalence of asthma worldwide
have resulted in increased morbidity and mor-
tality and have sparked renewed interest in both
basic and clinical research related to this disease.
Much of the newly acquired information
derived from this research was reviewed during
the workshop “Environmental Influences on
the Induction and Incidence of Asthma” and
this information is summarized in this and the
three subsequent articles in this mini-mono-
graph. In discussing potential actions that pub-
lic health agencies could take based on currently
available science, there is strong scientific sup-
port for efforts to limit in utero exposure to
cigarette smoke. However, with respect to other
potential types of interventions, participants
noted many more questions than answers. A
number of scientific questions were clearly
articulated, and it is apparent that public health
agencies are eager to have the answer to these
questions. Research to address these questions
could have a significant public health and
economic impact that would be well worth
the investment.
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